Vanderbilt University Medical (VUMC) researchers have received a $2.9 million federal grant to test the effectiveness of a new intervention that aims to help older patients reduce the number of medications they may be taking on a regular basis.

Modulation of T cell metabolism thus may represent a new therapeutic avenue for leukemia patients.

High levels of blood markers for vascular endothelial dysfunction were associated with longer periods of confusion in ICU patients, Vanderbilt researchers have discovered.

Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.

A protein called Gremlin 2 controls the extent of inflammation after heart attack and may be a good therapeutic target.

Researchers at Vanderbilt University Medical Center and Vanderbilt University have received a $1.9 million grant from the National Institutes of Health (NIH) to support research to restore vision through regeneration of the retina.

The sphere-forming frequency of neuroblastoma cells is a measure of their proliferative capacity and could help guide treatment strategies for neuroblastoma.